RecruitingN/Aketamine

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Sponsored by Tianjin Medical University General Hospital

NCT ID
NCT06108830
Target Enrollment
400 participants
Start Date
2023-12-01
Est. Completion
2024-12-10

About This Study

To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies

Conditions Studied

Sleep Disturbance

Interventions

  • Esketamine
  • Remimazolam
  • Esketamine and remimazolam
  • normal saline

Eligibility

Age:20 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. Age 20-65 years old;
2. ASA classification is grade I-III;
3. Elective surgery is proposed
4. BMI of 19-30 kg/m2;
5. Patients who agreed to enroll in this study voluntarily

Exclusion Criteria:

1. Those who are known to be allergic to the drug ingredients in this study and their allergic constitution;
2. Allergic history of general anesthesia drugs, opioid drugs, non-steroidal drugs;
3. History of neurological diseases; History of chronic pain; Drug and alcohol addiction; A long history of opioid use; Opiates were given 48 hours before surgery;
4. ASA rating of IV or V;
5. Coronary heart disease, bronchial asthma, severe hypertension, severe blood system dysfunction, liver and kidney function, electrolyte abnormalities;
6. History of gastrointestinal disease (peptic ulcer, Crohn's disease, ulcerative colitis);
7. Respiratory insufficiency, respiratory failure;
8. Patients who refused to use intravenous PCA for analgesia;
9. Pregnant or lactating women;
10. BMI\<18 kg/m2 or BMI\>30kg/m2;
11. Poor compliance, unable to complete the experiment according to the study plan;
12. Participants who have participated in clinical trials of other drugs within the last 4 weeks;
13. Any circumstances deemed unsuitable for inclusion by the researcher for any reason.

Study Locations (1)

Tianjin Medical University General Hospital
Tianjin, China

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients | Huxley